Literature DB >> 23960175

Timely completion of scientifically rigorous cancer clinical trials: an unfulfilled priority.

James H Doroshow1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23960175     DOI： 10.1200/JCO.2013.51.3192

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  Challenges Facing Early Phase Trials Sponsored by the National Cancer Institute: An Analysis of Corrective Action Plans to Improve Accrual.

Authors:  Holly A Massett; Grace Mishkin; Larry Rubinstein; S Percy Ivy; Andrea Denicoff; Elizabeth Godwin; Kate DiPiazza; Jennifer Bolognese; James A Zwiebel; Jeffrey S Abrams
Journal:  Clin Cancer Res       Date:  2016-07-11       Impact factor: 12.531

2.  Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.

Authors:  Chad Tang; Steven I Sherman; Mellanie Price; Jun Weng; Suzanne E Davis; David S Hong; James C Yao; Aman Buzdar; George Wilding; J Jack Lee
Journal:  Clin Cancer Res       Date:  2017-03-08       Impact factor: 12.531

3.  Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual.

Authors:  Chad Tang; Kenneth R Hess; Dwana Sanders; Suzanne E Davis; Aman U Buzdar; Razelle Kurzrock; J Jack Lee; Funda Meric-Bernstam; David S Hong
Journal:  Clin Cancer Res       Date:  2016-11-16       Impact factor: 12.531

4.  Understanding Willingness to Participate in Cancer Clinical Trials Among Patients and Caregivers Attending a Minority-Serving Academic Cancer Center.

Authors:  Tamar Ginossar; Claudia Diaz Fuentes; John Oetzel
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

5.  Access to clinical trials among oncology patients: results of a cross sectional survey.

Authors:  Mariko Carey; Allison W Boyes; Rochelle Smits; Jamie Bryant; Amy Waller; Ian Olver
Journal:  BMC Cancer       Date:  2017-09-18       Impact factor: 4.430

6.  Model of a Queuing Approach for Patient Accrual in Phase 1 Oncology Studies.

Authors:  Paul H Frankel; Vincent Chung; Joseph Tuscano; Tanya Siddiqi; Sagus Sampath; Jeffrey Longmate; Susan Groshen; Edward M Newman
Journal:  JAMA Netw Open       Date:  2020-05-01

7.  Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials.

Authors:  Timothy A Lin; Clifton David Fuller; Vivek Verma; Walker Mainwaring; Andres F Espinoza; Austin B Miller; Amit Jethanandani; Dario Pasalic; Prajnan Das; Bruce D Minsky; Charles R Thomas; David R Fogelman; Vivek Subbiah; Ishwaria M Subbiah; Ethan B Ludmir
Journal:  Cancers (Basel)       Date:  2020-09-16       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.